Shinichiro Uchiyama Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

1/2021	Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.
11/2019	Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.
1/2017	Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation .
12/2016	Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF.
2/2015	Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
1/2015	Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS).
11/2014	Ankle-brachial index and neurologic deterioration in acute ischemic stroke.
7/2013	[Antiplatelet therapy: update in secondary stroke prevention].
10/2010	Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
9/2009	[Transient ischemic attack, a medical emergency].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinichiro Uchiyama Research Topics

Disease

97	Stroke (Strokes) 07/2022 - 03/2002
60	Ischemic Stroke 07/2022 - 05/2002
48	Hemorrhage 07/2022 - 02/2006
40	Atrial Fibrillation 01/2022 - 11/2003
19	Embolism (Embolus) 01/2022 - 11/2002
19	Embolic Stroke 07/2021 - 11/2006
18	Hypertension (High Blood Pressure) 01/2021 - 11/2003
14	Cerebral Infarction 01/2019 - 03/2006
13	Transient Ischemic Attack 01/2022 - 07/2013
12	Hemorrhagic Stroke 07/2021 - 09/2003
11	Infarction (Infarctions) 01/2022 - 01/2009
10	Diabetes Mellitus 04/2018 - 10/2008
9	Thrombosis (Thrombus) 04/2018 - 10/2004
8	Pathologic Constriction (Stenosis) 07/2022 - 12/2010
8	Myocardial Infarction 10/2021 - 09/2003
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2019 - 07/2010
8	Dyslipidemias (Dyslipidemia) 01/2019 - 02/2009
7	Lacunar Stroke 05/2020 - 11/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 02/2020 - 01/2008
6	Atherosclerosis 02/2021 - 12/2009
5	Cerebral Hemorrhage 01/2021 - 01/2009
5	Hypercholesterolemia 09/2009 - 01/2008
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018 - 07/2010
4	Parkinson Disease (Parkinson's Disease) 01/2017 - 08/2011
4	Atherosclerotic Plaque (Atheroma) 01/2015 - 12/2007
4	Coronary Disease (Coronary Heart Disease) 02/2009 - 11/2003
3	Hyperlipidemias (Hyperlipidemia) 04/2018 - 02/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 12/2011
3	Ulcer 05/2014 - 06/2011
3	Vascular Diseases (Vascular Disease) 12/2011 - 11/2003
3	Heart Failure 01/2009 - 11/2003
2	Ischemia 09/2021 - 11/2010
2	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 08/2020 - 03/2015
2	Thromboembolism 02/2020 - 01/2014
2	Brain Infarction 01/2019 - 09/2016
2	Intracranial Embolism 06/2018 - 08/2012
2	Neoplasms (Cancer) 04/2018 - 02/2008
2	Inflammation (Inflammations) 10/2017 - 12/2010
2	Carotid Artery Diseases 11/2014 - 12/2007
2	Necrosis 10/2014 - 08/2012
2	Neuromyelitis Optica (Devic's Disease) 10/2013 - 01/2011
2	Multiple Sclerosis 10/2013 - 01/2011
2	Renal Insufficiency (Renal Failure) 01/2013 - 11/2011
2	Acute Coronary Syndrome 01/2012 - 01/2009
2	Myelitis 01/2011 - 10/2004
2	Spinal Cord Diseases 04/2010 - 10/2004
2	Obesity 09/2009 - 07/2007
2	Patent Foramen Ovale 11/2003 - 11/2002

Drug/Important Bio-Agent (IBA)

42	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2022 - 09/2003
29	RivaroxabanIBA 01/2022 - 01/2012
20	Warfarin (Coumadin)FDA LinkGeneric 06/2019 - 03/2002
18	AnticoagulantsIBA 01/2022 - 10/2004
17	Cilostazol (Pletal)FDA LinkGeneric 07/2022 - 11/2003
17	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2020 - 01/2008
16	Clopidogrel (Plavix)FDA Link 07/2022 - 12/2003
16	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 04/2006
16	Pravastatin (Pravachol)FDA LinkGeneric 06/2020 - 01/2008
12	Dabigatran FDA Link 01/2022 - 04/2011
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2022 - 07/2013
5	Factor Xa InhibitorsIBA 06/2018 - 04/2011
4	Prasugrel Hydrochloride FDA Link 02/2021 - 04/2018
4	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 01/2013
4	LDL CholesterolIBA 05/2020 - 09/2009
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2019 - 06/2008
4	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 04/2018 - 12/2014
4	LipidsIBA 01/2018 - 02/2009
4	Pharmaceutical PreparationsIBA 05/2014 - 01/2005
4	Ticlopidine (Ticlid)FDA LinkGeneric 07/2013 - 09/2003
3	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 11/2006
3	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2021 - 08/2012
3	LDL Lipoproteins (beta Lipoproteins)IBA 05/2020 - 01/2018
3	C-Reactive ProteinIBA 05/2019 - 10/2017
3	HDL CholesterolIBA 04/2018 - 10/2008
3	Biomarkers (Surrogate Marker)IBA 09/2016 - 10/2013
3	CholesterolIBA 02/2014 - 07/2007
3	Antiphospholipid AntibodiesIBA 11/2008 - 10/2004
2	Cytochrome P-450 CYP2C19IBA 03/2022 - 01/2019
2	Thrombin FDA Link 01/2021 - 11/2020
2	CreatinineIBA 11/2019 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 02/2004
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 05/2014
2	danaparoid (Orgaran)FDA Link 12/2015 - 05/2014
2	Dipyridamole (Persantine)FDA LinkGeneric 07/2013 - 01/2011
2	Vitamin K FDA Link 01/2013 - 04/2012
2	InterferonsIBA 01/2011 - 01/2011
2	CytokinesIBA 12/2010 - 02/2008
2	oxidized low density lipoproteinIBA 12/2009 - 09/2009
2	Hemostatics (Antihemorrhagics)IBA 01/2009 - 11/2006
2	ozagrelIBA 01/2009 - 11/2006
2	sarpogrelateIBA 06/2008 - 01/2007
1	idarucizumabIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 07/2021
1	ThienopyridinesIBA 01/2021

Therapy/Procedure

46	Therapeutics 07/2022 - 11/2003
19	Secondary Prevention 11/2020 - 01/2006
4	Drug Therapy (Chemotherapy) 05/2014 - 09/2004
2	Thrombectomy 01/2022 - 01/2018
2	Renal Dialysis (Hemodialysis) 01/2013 - 09/2004
1	Drug Tapering 05/2020
1	Blood Transfusion (Blood Transfusions) 02/2020